Return to Article Details
A CRITIQUE ONMECHANISM OF NIGELLA SATIVA AS AN ANTI-DIABETIC DRUG: FOCUS ON THE THERAPEUTIC DOSE BASED ON ASSORTED EXPLICATIONS